Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Advances in Rift Valley fever research: insights for disease prevention.

LaBeaud AD, Kazura JW, King CH.

Curr Opin Infect Dis. 2010 Oct;23(5):403-8. doi: 10.1097/QCO.0b013e32833c3da6. Review.

PMID:
20613512
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Rift valley fever: recent insights into pathogenesis and prevention.

Boshra H, Lorenzo G, Busquets N, Brun A.

J Virol. 2011 Jul;85(13):6098-105. doi: 10.1128/JVI.02641-10. Epub 2011 Mar 30. Review.

PMID:
21450816
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Rift valley fever vaccines.

Ikegami T, Makino S.

Vaccine. 2009 Nov 5;27 Suppl 4:D69-72. doi: 10.1016/j.vaccine.2009.07.046. Review.

PMID:
19837291
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.

Boshra H, Lorenzo G, Rodriguez F, Brun A.

Vaccine. 2011 Jun 15;29(27):4469-75. doi: 10.1016/j.vaccine.2011.04.043. Epub 2011 May 5.

PMID:
21549790
[PubMed - indexed for MEDLINE]
5.

Novel approaches to develop Rift Valley fever vaccines.

Indran SV, Ikegami T.

Front Cell Infect Microbiol. 2012 Oct 26;2:131. doi: 10.3389/fcimb.2012.00131. eCollection 2012. Review.

PMID:
23112960
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Field evaluation of a wicking assay for the rapid detection of Rift Valley fever viral antigens in mosquitoes.

Wanja E, Parker Z, Rowland T, Turell MJ, Clark JW, Davé K, Davé S, Sang R.

J Am Mosq Control Assoc. 2011 Dec;27(4):370-5.

PMID:
22329268
[PubMed - indexed for MEDLINE]
7.

Breaking the chain: Rift Valley fever virus control via livestock vaccination.

Bird BH, Nichol ST.

Curr Opin Virol. 2012 Jun;2(3):315-23. doi: 10.1016/j.coviro.2012.02.017. Epub 2012 Mar 29. Review.

PMID:
22463980
[PubMed - indexed for MEDLINE]
8.

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, Moormann RJ.

Vaccine. 2010 Jun 17;28(27):4394-401. doi: 10.1016/j.vaccine.2010.04.048. Epub 2010 Apr 29.

PMID:
20434545
[PubMed - indexed for MEDLINE]
9.

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.

López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2309. doi: 10.1371/journal.pntd.0002309. Print 2013.

PMID:
23875044
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

One Health approach to Rift Valley fever vaccine development.

Kortekaas J.

Antiviral Res. 2014 Jun;106:24-32. doi: 10.1016/j.antiviral.2014.03.008. Epub 2014 Mar 26. Review.

PMID:
24681125
[PubMed - indexed for MEDLINE]
11.

[Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].

Wang QH, Wang XJ, Hu S, Ge JY, Bu ZG.

Wei Sheng Wu Xue Bao. 2007 Aug;47(4):677-81. Chinese.

PMID:
17944371
[PubMed - indexed for MEDLINE]
12.

Observations on rift valley fever virus and vaccines in Egypt.

Ahmed Kamal S.

Virol J. 2011 Dec 12;8:532. doi: 10.1186/1743-422X-8-532. Review.

PMID:
22152149
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines.

Ayari-Fakhfakh E, do Valle TZ, Guillemot L, Panthier JJ, Bouloy M, Ghram A, Albina E, Cêtre-Sossah C.

J Gen Virol. 2012 Jul;93(Pt 7):1456-64. doi: 10.1099/vir.0.042754-0. Epub 2012 Apr 18.

PMID:
22513390
[PubMed - indexed for MEDLINE]
Free Article
14.

Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.

Gowen BB, Bailey KW, Scharton D, Vest Z, Westover JB, Skirpstunas R, Ikegami T.

Antiviral Res. 2013 May;98(2):135-43. doi: 10.1016/j.antiviral.2013.03.009. Epub 2013 Mar 21.

PMID:
23523764
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003.

Faye O, Diallo M, Diop D, Bezeid OE, Bâ H, Niang M, Dia I, Mohamed SA, Ndiaye K, Diallo D, Ly PO, Diallo B, Nabeth P, Simon F, Lô B, Diop OM.

Emerg Infect Dis. 2007 Jul;13(7):1016-23. doi: 10.3201/eid1307.061487.

PMID:
18214173
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Rift valley fever].

Markin VA, Pantiukhov VB, Markov VI, Bondarev VP.

Zh Mikrobiol Epidemiol Immunobiol. 2012 Sep-Oct;(5):95-103. Review. Russian.

PMID:
23163047
[PubMed - indexed for MEDLINE]
17.

Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Jansen van Vuren P, Tiemessen CT, Paweska JT.

PLoS One. 2011;6(9):e25027. doi: 10.1371/journal.pone.0025027. Epub 2011 Sep 16.

PMID:
21949840
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J.

Vet Res. 2010 Nov-Dec;41(6):61.

PMID:
21188836
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Molecular biology and genetic diversity of Rift Valley fever virus.

Ikegami T.

Antiviral Res. 2012 Sep;95(3):293-310. doi: 10.1016/j.antiviral.2012.06.001. Epub 2012 Jun 16. Review.

PMID:
22710362
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, Furuta Y, Gowen BB.

Antiviral Res. 2014 Apr;104:84-92. doi: 10.1016/j.antiviral.2014.01.016. Epub 2014 Jan 31.

PMID:
24486952
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk